Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment.

Explore this paper's citation graph

Summary

Versican silencing in the tumor microenvironment offers a promising approach to reverse the tumor refractoriness to antiangiogenic therapies.

Type
article
Published
2015-06-01
Cited by
36
References
32
Access
Open access

Keywords

Geography

References

Cited by

Related papers

No related papers recorded.